A range of host factors, encompassing the status of tumor and solute PD‐L1, microsatellite instability (MSI), TMB, oncogenic signaling, epigenetic regulation, circulating tumor DNA (ctDNA) and infiltrating lymphocytes, routine emerging inflammatory markers and cytokines, as well as gut microbiota, have been extensively investigated. The gene discussed is CD274; the disease is neoplasm.